Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Early treatment of class III malocclusion.

Kumar A, Rohilla A, Tandon P, Nager A.

Int J Orthod Milwaukee. 2014 Summer;25(2):41-5.

PMID:
25109058
2.

Reply to Jones and Niederweis.

Reddy PV, Puri RV, Chauhan P, Kar R, Rohilla A, Khera A, Tyagi AK.

J Infect Dis. 2014 Mar;209(6):971-2. doi: 10.1093/infdis/jit605. Epub 2013 Nov 17. No abstract available.

3.

Disruption of mycobactin biosynthesis leads to attenuation of Mycobacterium tuberculosis for growth and virulence.

Reddy PV, Puri RV, Chauhan P, Kar R, Rohilla A, Khera A, Tyagi AK.

J Infect Dis. 2013 Oct 15;208(8):1255-65. doi: 10.1093/infdis/jit250. Epub 2013 Jun 20.

4.

Optimization and formulation design of carbopol loaded Piroxicam gel using novel penetration enhancers.

Chaudhary H, Rohilla A, Rathee P, Kumar V.

Int J Biol Macromol. 2013 Apr;55:246-53. doi: 10.1016/j.ijbiomac.2013.01.015. Epub 2013 Jan 31.

PMID:
23376559
5.

Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heart.

Rohilla A, Khan MU, Khanam R.

J Adv Pharm Technol Res. 2012 Jul;3(3):193-8. doi: 10.4103/2231-4040.101018.

6.

Tertiary dentinogenesis with calcium hydroxide: a review of proposed mechanisms.

Sangwan P, Sangwan A, Duhan J, Rohilla A.

Int Endod J. 2013 Jan;46(1):3-19. doi: 10.1111/j.1365-2591.2012.02101.x. Epub 2012 Aug 13. Review.

PMID:
22889347
7.

Myocardial postconditioning: next step to cardioprotection.

Rohilla A, Rohilla S, Kushnoor A.

Arch Pharm Res. 2011 Sep;34(9):1409-15. doi: 10.1007/s12272-011-0901-x. Epub 2011 Oct 6. Review.

PMID:
21975801
8.

Pleiotropic actions of fenofibrate on the heart.

Balakumar P, Rohilla A, Mahadevan N.

Pharmacol Res. 2011 Jan;63(1):8-12. doi: 10.1016/j.phrs.2010.11.002. Epub 2010 Nov 18. Review.

PMID:
21093591
9.

Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?

Balakumar P, Rohilla A, Thangathirupathi A.

Pharmacol Res. 2010 Sep;62(3):179-86. doi: 10.1016/j.phrs.2010.04.004. Epub 2010 Apr 29. Review.

PMID:
20434560
10.

The multifaceted therapeutic potential of benfotiamine.

Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A.

Pharmacol Res. 2010 Jun;61(6):482-8. doi: 10.1016/j.phrs.2010.02.008. Epub 2010 Feb 25. Review.

PMID:
20188835
11.

The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: the reasonable role of PKC-delta.

Rohilla A, Balakumar P.

Biomed Pharmacother. 2009 Dec;63(10):787-91. doi: 10.1016/j.biopha.2009.06.012. Epub 2009 Oct 14.

PMID:
19914793
12.

Possible involvement of PKC-delta in the abrogated cardioprotective potential of ischemic preconditioning in hyperhomocysteinemic rat hearts.

Rohilla A, Singh G, Singh M, Bala kumar P.

Biomed Pharmacother. 2010 Mar;64(3):195-202. doi: 10.1016/j.biopha.2009.04.030. Epub 2009 Oct 17.

PMID:
19914792
13.

Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.

Balakumar P, Rohilla A, Singh G, Singh K, Singh M.

Methods Find Exp Clin Pharmacol. 2009 Mar;31(2):71-9. doi: 10.1358/mf.2009.31.2.1357292.

PMID:
19455261
14.
15.

Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?

Balakumar P, Rohilla A, Singh M.

Pharmacol Res. 2008 Jun;57(6):403-12. doi: 10.1016/j.phrs.2008.05.006. Epub 2008 Jun 30. Review.

PMID:
18586514
16.

Alterations in macromolecular composition and cell wall integrity by ciprofloxacin in Mycobacterium smegmatis.

Verma I, Rohilla A, Khuller GK.

Lett Appl Microbiol. 1999 Aug;29(2):113-7.

PMID:
10499299
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk